0 Reacties
0 aandelen
96 Views
0 voorbeeld
Zoeken
Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken
-
Please log in to like, share and comment!
-
Long-Acting Injectable Oncology Drug Market Size Forecast and Segment AnalysisAccording to the latest report published by Data Bridge Market Research, the Long-Acting Injectable Oncology Drug Market The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period Quality and transparency has been strictly maintained while carrying...0 Reacties 0 aandelen 182 Views 0 voorbeeld
-
2,4-Dichloropyrimidine Market to Reach USD 285.4 Million by 2032, Driven by Oncology Drug Demand and Pharmaceutical OutsourcingGlobal 2,4-Dichloropyrimidine market, valued at approximately USD 162.5 Million in 2025, is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 7.4%, reaching an estimated USD 285.4 Million by 2032. The market's expansion is fueled by increasing demand for oncology treatments, expanding pharmaceutical R&D activities, growing pharmaceutical outsourcing to Asian manufacturing...0 Reacties 0 aandelen 191 Views 0 voorbeeld
-
Asia Pacific Cryoablation Market Expands With Advancements in Precision OncologyThe Asia Pacific cryoablation market is emerging as a significant segment within the broader minimally invasive medical treatment landscape. Cryoablation, a technique that uses extreme cold to destroy abnormal or diseased tissues, is increasingly being adopted for treating cancers, cardiac arrhythmias, and other chronic conditions. The region’s growing burden of cancer and cardiovascular...0 Reacties 0 aandelen 463 Views 0 voorbeeld
-
Biosimilar Bevacizumab Market - Anti-Angiogenic Cancer Therapy and Cost-Effective OncologyMarket Overview The global Biosimilar Bevacizumab Market is experiencing explosive growth driven by anti-angiogenic cancer therapy demand, cost-effective oncology emphasis, and biosimilar regulatory pathway maturation. The global biosimilar bevacizumab market is projected to exceed USD 30 billion through 2030, fueled by colorectal cancer treatment expansion, non-small cell lung cancer adoption,...0 Reacties 0 aandelen 174 Views 0 voorbeeld
-
Brachytherapy Device Market: Cancer Treatment Innovation, Targeted Radiation Therapy Growth, and Advanced Radioisotope Technology Driving Specialized Oncology Device DemandThe Brachytherapy Device Market is experiencing significant growth as cancer treatment innovation accelerates, targeted radiation therapy adoption increases, and advanced radioisotope technology enables more precise, effective, and patient-friendly cancer treatment options across diverse tumor types and clinical settings. Brachytherapy is a form of radiation therapy in which radioactive sources...0 Reacties 0 aandelen 37 Views 0 voorbeeld
-
Can Next-Generation Oncology Treatments Strengthen the Taxane Market?According to the latest report published by Data Bridge Market Research, the Taxane Market CAGR Value The Taxane Market was valued at USD 5.50 billion in 2025 and is projected to reach USD 8.31 billion by 2033, growing at a CAGR of 5.30% from 2026 to 2033. The world-class Taxane Market report analyses some of the challenges that Taxane Market industry may have to face during the...0 Reacties 0 aandelen 241 Views 0 voorbeeld
-
Challenges and Barriers in the Radiation Oncology MarketDespite its promising growth trajectory, the radiation oncology market faces significant challenges that can impede adoption, limit access, and constrain market expansion. Understanding these barriers is essential for healthcare providers, policymakers, and industry stakeholders working to improve cancer care delivery. For analysis of market challenges and opportunities, refer to...0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
Expanding Stem Cell Research and Oncology Biomarker Discovery Driving Growth in Lgr5 Antibody ApplicationsThe Global LGR5 Antibody Market represents a specialized and rapidly growing segment of the biotechnology and pharmaceutical research industry. Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) is a well-established marker of adult stem cells in multiple tissues, including the intestine, stomach, and hair follicles. Critically, LGR5 has also been identified as a...0 Reacties 0 aandelen 796 Views 0 voorbeeld
-
Experts Reveal the Future of the Hormone-Refractory Oncology Drug MarketAccording to the latest report published by Data Bridge Market Research, the Hormone-Refractory Oncology Drug Market CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period This Hormone-Refractory Oncology Drug Market research...0 Reacties 0 aandelen 200 Views 0 voorbeeld
-
Galectin Inhibitor Therapeutics Market Report: Oncology Drug Innovation"According to the latest report published by Data Bridge Market Research, the Galectin Inhibitor Therapeutics Market Global galectin inhibitor therapeutics market size was valued at USD 187.39 million in 2024 and is projected to reach USD 339.21 million by 2032, with a CAGR of 7.7% during the forecast period of 2025 to 2032. A number of aspects that are kept into view while creating...0 Reacties 0 aandelen 128 Views 0 voorbeeld
-
Generic Oncology Drug Market: Healthcare System Cost Pressures, Insurance Coverage, and Reimbursement DynamicsThe Generic Oncology Drug Market is being significantly influenced by healthcare system cost pressures, evolving insurance coverage policies, and complex reimbursement dynamics that are shaping market access and adoption. As healthcare costs continue to rise globally, payers, governments, and healthcare systems are increasingly focused on cost containment strategies, with generic oncology drugs...0 Reacties 0 aandelen 23 Views 0 voorbeeld
-
Cancer Treatment Drugs Market Share AnalysisGlobal Demand Outlook for Executive Summary Cancer Therapeutics Market Size and Share The Cancer Therapeutics Market is witnessing substantial growth due to the increasing global burden of cancer, rising investments in oncology research, and growing adoption of advanced precision medicine technologies. Cancer therapeutics have become essential components of modern healthcare systems,...0 Reacties 0 aandelen 338 Views 0 voorbeeld
-
High-Potency Oncology API (HPAPI) Market Size Expected to Grow Significantly During 2026–2032 Driven by Rising Demand for Targeted Cancer Therapies"High-Potency Oncology API (HPAPI) Market Summary: According to the latest report published by Data Bridge Market Research, the High-Potency Oncology API (HPAPI) Market The global High-Potency Oncology API (HPAPI) market size was valued at USD 693 Million in 2025 and is expected to reach USD 1421.90 Million by 2033, at a CAGR of 9.40% during the forecast period The reliable...0 Reacties 0 aandelen 447 Views 0 voorbeeld
-
How Is Genetic Risk Awareness Driving the North America Hereditary Cancer Testing Market?According to the latest report published by Data Bridge Market Research, the North America Hereditary Cancer Testing Market CAGR Value The North America hereditary cancer testing market size was valued at USD 3.39 billion in 2025 and is expected to reach USD 9.20 billion by 2033, at a CAGR of 13.3% during the forecast period Market research analysis and data in this North...0 Reacties 0 aandelen 303 Views 0 voorbeeld
-
How Is the Implantable Ports Market Advancing Long-Term Drug Delivery Systems?Key Drivers Impacting Executive Summary Implantable Ports Market Size and Share CAGR Value Data Bridge Market Research analyzes that the global implantable ports Market is expected to grow at a CAGR of 7.8% during the forecast period of 2023 to 2030. The large-scale Implantable Ports Market report presents the best market and business solutions to Implantable Ports Market industry in...0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
How Is the Tumor Markers Testing Market Improving Early Cancer Detection?According to the latest report published by Data Bridge Market Research, the Tumor Markers Testing Market CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow...0 Reacties 0 aandelen 25 Views 0 voorbeeld
-
How Is Tumor Markers Testing Market Advancing Early Cancer Diagnosis?Executive Summary Tumor Markers Testing Market: Share, Size & Strategic Insights CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow to USD 30.23 billion by 2030....0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
Kidney Cancer Diagnostics Market Trends, Innovation & Global Forecast"Kidney Cancer Diagnostics Market According to the latest report published by Data Bridge Market Research, the Kidney Cancer Diagnostics Market Data Bridge Market Research analyzes that the kidney cancer diagnostics market is expected to reach a value of USD 16,862.32 million by 2030, at a CAGR of 6.4% during the forecast period. Imaging accounts for the largest test type segment in...0 Reacties 0 aandelen 232 Views 0 voorbeeld
-
Middle East Cancer Radiation Therapy Market to Reach US$ 1,243.7 Million by 2031 at a CAGR of 10.2%Cancer radiation therapy, commonly referred to as radiotherapy, is a highly effective cancer treatment that uses controlled doses of high-energy radiation—including X-rays, gamma rays, proton beams, or other particle beams—to destroy cancer cells and reduce tumor size. The treatment damages the genetic material (DNA) of cancer cells, preventing them from growing and multiplying...0 Reacties 0 aandelen 147 Views 0 voorbeeld
-
North America Cancer Hormone Therapy Market to Grow at a CAGR of 12.1% During 2025–2031Hormone therapy, or endocrine therapy, is an effective treatment used to manage cancers that rely on hormones for growth. It works by reducing the production of specific hormones or blocking their ability to stimulate cancer cells, thereby slowing or preventing tumor progression. This approach is widely used to treat hormone-sensitive cancers such as breast, prostate, endometrial, ovarian, and...0 Reacties 0 aandelen 128 Views 0 voorbeeld
-
Oncology Based Molecular Diagnostics Market Demand Accelerates with Genomic Cancer TestingThe rapid evolution of cancer molecular diagnostics, increasing adoption of molecular diagnostics in oncology, and growing demand for precision oncology diagnostics are transforming cancer detection and treatment worldwide. Molecular diagnostic technologies enable healthcare professionals to identify genetic mutations, biomarkers, and tumor-specific molecular characteristics, supporting earlier...0 Reacties 0 aandelen 111 Views 0 voorbeeld
Zoekresultaten
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
